Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.

Breast cancer research and treatment - 1 Nov 2010

Qiu Li-Xin, Yao Lei, Zhang Jian, Zhu Xiao-Dong, Zhao Xin-Min, Xue Kai, Mao Chen, Chen Bo, Zhan Ping, Yuan Hui, Hu Xi-Chun

Abstract excerpt

Published data on the association between Xeroderma Pigmentosum complementation group D (XPD) Lys751Gln polymorphism and breast cancer risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. Crude ORs with 95% CIs were used to assess the strength of association between them. A total of 30 studies including 14,283 cases and 14,426 controls were involved in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Odds Ratio

Share to Polymorphism, Genetic

Share to Risk Assessment

Share to Risk Factors

Share to Xeroderma Pigmentosum Group D Protein

Source

Identifiers

PMID: 20204500
DOI: 10.1007/s10549-010-0813-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.PMID 20204500Read ↗

XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Associations between XPD polymorphisms and risk of breast cancer: a meta-analysis.Semantic proximity Read ↗

Contribution of xeroderma pigmentosum complementation group D gene polymorphisms in breast and ovarian cancer susceptibility: A protocol for systematic review and meta analysis.Semantic proximity Read ↗

Association between XPD Lys751Gln polymorphism and bladder cancer susceptibility: an updated and cumulative meta-analysis based on 6,836 cases and 8,251 controls.Semantic proximity Read ↗

Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.Semantic proximity Read ↗

Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects.Semantic proximity Read ↗

Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.Semantic proximity Read ↗

XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.Semantic proximity Read ↗

Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.Semantic proximity Read ↗

XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.Semantic proximity Read ↗

Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin's lymphoma: evidence from a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.